Cost and Time Benefits of Interchangeable Biosimilars
Kimberly C. Chen, DO, MSHLM, discusses the potential benefits of interchangeable biosimilars to patients and payers.
United States Jonathan Kay Ryan Haumschild Kaiser Permanente Kimberlyc Chen Interchangeable Biosimilars
Source: ajmc.com